From: Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals
Treatment
Relative expression of p53
DIL 20 µg/ml
1.06 ± 0.65
DOX 0.25 µg/ml
1.20 ± 0.64
DOX 0.25 µg/ml + DIL 20 µg/ml
1.71 ± 1.4
DOX 1 µg/ml
1.43 ± 1.5
DOX 1 µg/ml + DIL 20 µg/ml
2.21 ± 1.1a